VeriMomsoy isoflavones est-il sûr pendant la grossesse ?
Although the CIR review concluded soy‑derived ingredients used in cosmetics are safe as used, multiple peer‑reviewed animal and human biomonitoring studies show isoflavones (particularly genistein/daidzein) have estrogenic activity and have produced developmental/reproductive effects in some animal dosing studies; genistein is also identified as an endocrine‑active substance in ECHA records. Topical cosmetic use is expected to give low but measurable systemic exposure compared with ingestion. (CIR review; PubMed animal/developmental studies; ECHA substance information).
Alternatives sûres à soy isoflavones pendant la grossesse | VeriMom
Related ingredients
Frequently asked questions
- soy isoflavones est-il sûr pendant la grossesse ?
- Although the CIR review concluded soy‑derived ingredients used in cosmetics are safe as used, multiple peer‑reviewed animal and human biomonitoring studies show isoflavones (particularly genistein/daidzein) have estrogenic activity and have produced developmental/reproductive effects in some animal dosing studies; genistein is also identified as an endocrine‑active substance in ECHA records. Topical cosmetic use is expected to give low but measurable systemic exposure compared with ingestion. (CIR review; PubMed animal/developmental studies; ECHA substance information).
- soy isoflavones est-il sûr pendant l'allaitement ?
- Isoflavones are measurable in human maternal serum and breast milk in studies and have estrogenic activity; animal studies of perinatal exposure report effects on offspring reproductive development, so reproductive concern is present under systemic exposure scenarios. Cosmetic topical use usually results in low systemic exposure, so exposure is low but not zero. (Human biomonitoring and animal studies; CIR; ECHA).
- soy isoflavones est-il sûr pour la peau de bébé ?
- Infant/juvenile animal studies with neonatal/perinatal exposure to soy isoflavones (genistein/daidzein) show altered reproductive development; because infant skin has higher absorption/surface‑area‑to‑weight, topical exposure that gives measurable systemic uptake in adults is plausibly moderate in infants (adult e=1 → infant e=2). There are documented measurements of isoflavones in infants following dietary exposure, supporting potential systemic availability. (PubMed neonatal/ developmental studies; biomonitoring reviews).
- Comment VeriMom évalue-t-il soy isoflavones ?
- VeriMom évalue soy isoflavones à 40/100 (risque moyen) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à soy isoflavones pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à soy isoflavones basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.